- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04008459
Walking and Balance Related to Sagittal Spinal Posture Alignment (WiSPA)
September 10, 2020 updated by: University of Oxford
WiSPA: Walking and Balance Related to Sagittal Spinal Posture and Alignment
This study aims to improve understanding of the relationship between spinal alignment and walking and balance in people who have degenerative spinal conditions.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This prospective cohort study will include people who are attending physiotherapy to address a degenerative spinal condition and measure them longitudinally.
The investigators will measure spinal alignment, walking capacity and pattern, dynamic balance, and back muscle strength along with self-reported measures that reflect the person's functional self-efficacy, quality of life, and general health.
Physical and self-reported outcome measures will be assessed at baseline before the physiotherapy-led exercise class commences, after completion at 6 weeks, and 6 months post baseline.
Study Type
Observational
Enrollment (Actual)
41
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oxon
-
Oxford, Oxon, United Kingdom, OX4 1TH
- Nuffield Orthopaedic Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adults with a degenerative spinal condition who have been referred to outpatient physiotherapy treatment.
Description
Inclusion Criteria:
- Participant is diagnosed with a degenerative spinal condition.
- Participant is willing and able to give informed consent for participation in the study.
- Men and women aged 18 years or older.
- Participant is able to understand and participate safely in a physiotherapy measurement assessment.
- Participant is enrolled in physiotherapy.
Exclusion Criteria:
- Participant is unable to stand independently.
- Participant has a neurological condition which alters motor function and/or postural control.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Degenerative musculoskeletal spinal conditions
Participants are included who are enrolled in a 6-week physiotherapy exercise class aimed at improving function in people with degenerative spinal conditions.
|
Physiotherapy exercise class includes education, stretching, strengthening, posture and balance interventions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in sagittal spinal alignment
Time Frame: 6 weeks post-baseline
|
Alignment of the spine in the sagittal plane measured by a surface topography method
|
6 weeks post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sagittal spinal alignment
Time Frame: 6 months
|
Alignment of the spine in the sagittal plane measured by a surface topography method
|
6 months
|
2 minute walk test
Time Frame: 6 weeks and 6 months
|
Distance walked in 2 minutes to measure exercise capacity
|
6 weeks and 6 months
|
Gait analysis
Time Frame: 6 weeks and 6 months
|
Spatiotemoral gait parameters measured using inertial measurement units
|
6 weeks and 6 months
|
Tragus to wall distance
Time Frame: 6 weeks and 6 months
|
Forward posture measurement using the distance from the ear to the wall
|
6 weeks and 6 months
|
Four Square Step Test
Time Frame: 6 weeks and 6 months
|
Dynamic balance test involving multidirectional stepping over obstacles
|
6 weeks and 6 months
|
Timed loaded standing test
Time Frame: 6 weeks and 6 months
|
Measurement of back extensor muscle strength and endurance
|
6 weeks and 6 months
|
36-item Short Form Health Survey (SF-36)
Time Frame: 6 weeks and 6 months
|
Health survey measuring aspects of quality of life.
The questionnaire contains 36 questions which form 8 subscales: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health.
Each question is directly transformed into a 0-100 scale with the lower the score the more disability.
|
6 weeks and 6 months
|
Visual analogue pain scale
Time Frame: 6 weeks and 6 months
|
Measurement of pain in a participant's back.
The scale is along a horizontal 10 cm line with markings from 0 to 10, 0 indicating no pain and 10 indicating the worst pain imaginable.
|
6 weeks and 6 months
|
Activities-specific Balance Confidence Scale
Time Frame: 6 weeks and 6 months
|
Questionnaire measuring balance confidence in various situations.
It contains 16 questions in which participants rate their confidence in performing the activities on a scale from 0-100, 0 representing no confidence and 100 representing complete confidence.
The total score is calculated to be on a similar 0 to 100 scale.
|
6 weeks and 6 months
|
Modified gait efficacy scale
Time Frame: 6 weeks and 6 months
|
Questionnaire measuring walking confidence and self-efficacy.
Each of the 10 items is scored on a 10-point Likert scale with 1 representing no confidence and 10 representing complete confidence.
The total score ranges from 10-100.
|
6 weeks and 6 months
|
Sagittal spinal alignment
Time Frame: Within 2 weeks of baseline
|
Reliability re-test of alignment of the spine in the sagittal plane measured by a surface topography method
|
Within 2 weeks of baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erin Hannink, DPT, University of Oxford
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 6, 2019
Primary Completion (Actual)
July 12, 2020
Study Completion (Actual)
August 18, 2020
Study Registration Dates
First Submitted
June 27, 2019
First Submitted That Met QC Criteria
July 3, 2019
First Posted (Actual)
July 5, 2019
Study Record Updates
Last Update Posted (Actual)
September 14, 2020
Last Update Submitted That Met QC Criteria
September 10, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14031
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruitingPost Menopausal OsteoporosisFrance
-
AmgenCompletedPost Menopausal OsteoporosisFrance
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisSpain, South Africa, Germany, Mexico, United States, Canada, France, United Kingdom, Italy, Belgium, Australia, Poland, Denmark, Hungary, Czech Republic, Norway
-
Hoffmann-La RocheGlaxoSmithKlineCompletedPost Menopausal OsteoporosisFrance
-
Novartis PharmaceuticalsCompletedPost-menopausal OsteoporosisColombia, Belgium, Sweden, Hong Kong, United States, Hungary, Switzerland, Australia, Germany, Italy, Canada, Poland, Argentina, Thailand, Norway, New Zealand, France, Finland
Clinical Trials on Therapeutic exercise class
-
Dartmouth-Hitchcock Medical CenterParkinson's Disease FoundationTerminatedParkinson's DiseaseUnited States
-
Institute of Technology, SligoSligo General HospitalCompleted
-
Milton S. Hershey Medical CenterPennsylvania American Academy of PediatricsCompleted
-
Cedars-Sinai Medical CenterJewish Family Service; Partners In Care Foundation; AARP FoundationActive, not recruitingFall | Social IsolationUnited States
-
University of AlbertaCompleted
-
University of ValenciaRecruitingMotor Imagery | Therapeutic Exercise | Action ObservationSpain
-
Dr. John BartlettSligo General Hospital; Institute of Technology, SligoUnknown
-
Vanderbilt University Medical CenterUnited States Department of DefenseCompletedParkinson's Disease and Parkinsonism | Glymphatic SystemUnited States
-
Catholic University of the Sacred HeartCompletedShoulder Impingement SyndromeItaly
-
University of AlbertaCross Cancer InstituteCompletedHead and Neck Neoplasms | Fatigue | Accessory Nerve InjuryCanada